[Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Clin Ter, 1979/4/30;89(2):127-49.
Bucalossi A, Buzzelli G, D'Alessandro A
PMID: 226307
MeSH terms
Adult; Aged; Cholesterol; Clofibrate; Drug Evaluation; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Nicotinic Acids; Triglycerides
More resources
EndNote: Download